EyePoint Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
22.01.24
/
50%
€21.60
Target price
22.01.25
€32.12
Performance (%)
-61.75%
End price
23.01.25
€8.26
Summary
This prediction ended on 23.01.25 with a price of €8.26. The BUY prediction by JPMorgan_Chase___Co_ for EyePoint Pharmaceuticals Inc. performed very badly with a performance of -61.75%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 6.034% | 6.034% | 57.895% |
| iShares Core DAX® | 4.572% | 3.428% | 8.167% |
| iShares Nasdaq 100 | 1.832% | -1.036% | 34.659% |
| iShares Nikkei 225® | -0.289% | 3.380% | 61.852% |
| iShares S&P 500 | 2.229% | 0.472% | 25.073% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $35.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.68
13.08.24
13.08.24
€26.50
13.08.25
13.08.25
18.65%
14.08.25
14.08.25
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.46
04.06.24
04.06.24
€29.43
04.06.25
04.06.25
-15.94%
05.06.25
05.06.25